Insight Molecular Diagnostics: Q3 Earnings Snapshot

详细摘要
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter. On a per-share basis, the…
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter.
On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 10 cents. Losses, adjusted for non-recurring gains, came to 19 cents per share.
The cancer diagnostic test developer posted revenue of $559,000 in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX
文章开头,摘自Yahoo Finance。如需阅读全文,请前往媒体网站。
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (finance.yahoo.com)



